You are viewing an incomplete version of our website. Please click to reload the website as full version.

BIM antibody (BCL2-Like 11 (Apoptosis Facilitator)) (pSer69)

Details for Product anti-BCL2L11 Antibody No. ABIN965668, Supplier: Log in to see
Antigen
  • bim
  • BAM
  • BIM
  • BOD
  • 1500006F24Rik
  • Bim
  • Bod
  • BimL
  • BIMEL
  • BCL2-like 11
  • BCL2-like 11 (apoptosis facilitator)
  • bcl2l11
  • LOC100345483
  • BCL2L11
  • Bcl2l11
Alternatives
anti-Human BIM antibody for ELISA
Epitope
pSer69, pSer65
76
19
17
16
13
13
13
13
11
10
8
6
6
5
4
4
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
Reactivity
Human, Mouse (Murine), Rat (Rattus)
312
170
137
4
2
2
2
2
2
Host
Rabbit
266
30
18
13
7
Conjugate
This BIM antibody is un-conjugated
16
14
10
8
8
8
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
Application
Immunohistochemistry (IHC)
260
136
116
66
53
40
36
24
14
8
5
4
3
2
2
2
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Immunogen The antiserum was produced against synthesized phosphopeptide derived from human BIM around the phosphorylation site of serine 69 (P-A-SP-P-G).
Specificity BIM (phospho-Ser69/65) antibody detects endogenous levels of BIM only when phosphorylated at serine 69/65.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using nonphosphopeptide corresponding to the phosphorylation site.
Alternative Name BIM (BCL2L11 Antibody Abstract)
Pathways PI3K-Akt Signaling, Neurotrophin Signaling Pathway
Application Notes IHC: 1:50-1:100.
Restrictions For Research Use only
Format Liquid
Concentration 100ug/100ul.
Buffer Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Product cited in: Fukazawa, Noguchi, Masumi, Murakami, Uehara: "BimEL is an important determinant for induction of anoikis sensitivity by mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitors." in: Molecular cancer therapeutics, Vol. 3, Issue 10, pp. 1281-8, 2004 (PubMed).

Luciano, Jacquel, Colosetti, Herrant, Cagnol, Pages, Auberger: "Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function." in: Oncogene, Vol. 22, Issue 43, pp. 6785-93, 2003 (PubMed).